These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Use of the antibiotic erythromycin in intestinal motility disorders]. Rathgeber J; Burchardi H Anaesthesist; 1998 Jun; 47(6):523-4. PubMed ID: 9676314 [No Abstract] [Full Text] [Related]
27. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952 [TBL] [Abstract][Full Text] [Related]
28. Update on drugs for gastro-oesophageal reflux disease. Keady S Arch Dis Child Educ Pract Ed; 2007 Aug; 92(4):ep114-8. PubMed ID: 17644666 [No Abstract] [Full Text] [Related]
29. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
30. A severe case of odynophagia. Kuhlmann JB; Blum HE; Kreisel W; Fischer R BMJ; 2011 Jul; 343():d3137. PubMed ID: 21752845 [No Abstract] [Full Text] [Related]
31. [Stomach ulcer. Physiologenetic aspects and therapy with special reference to carbenoxolone]. Bianchi Porro G; Petrillo M Recenti Prog Med; 1976 Jul; 62(1):23-45. PubMed ID: 1037032 [No Abstract] [Full Text] [Related]
32. [Metoclopramide in the treatment of gastric functional disorders]. Tkaczewski W; Gebicki L; Chojnacki J; Rynkiewicz K Wiad Lek; 1980 Oct; 33(19):1531-4. PubMed ID: 7467325 [No Abstract] [Full Text] [Related]
33. Gastrointestinal motility testing--a personal perspective. Quigley EM Ir Med J; 1995; 88(6):210-2. PubMed ID: 8575921 [TBL] [Abstract][Full Text] [Related]
34. The pharmacological management of gastroesophageal reflux disease. Lowe RC; Wolfe MM Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198 [TBL] [Abstract][Full Text] [Related]
35. [Use of a metoclopramide-carbenoxolone combination in duodenal reflux pathology]. Procacciante F; Pronio A; Perri S; Catani M; Montesani C; Citone G; Ribotta G Minerva Chir; 1987 Oct; 42(19):1487-90. PubMed ID: 3683907 [No Abstract] [Full Text] [Related]
36. Gastrointestinal motility tests--when to call the motility lab? Quigley EM; Byrne KG Nebr Med J; 1994 Nov; 79(11):367-71. PubMed ID: 7830840 [No Abstract] [Full Text] [Related]
37. [Motility disorders as a pathogenetic principle: stomach and pylorus]. Blum AL Z Gastroenterol Verh; 1977; (13):115-7. PubMed ID: 80070 [No Abstract] [Full Text] [Related]
38. [Use of adrenergic substances in motor disorders of the large intestine]. Rozenbaum IuM Klin Med (Mosk); 1976 Jan; 54(1):56-60. PubMed ID: 1011700 [No Abstract] [Full Text] [Related]
39. Some complications of diphenoxylate hydrochloride with atropine. Uthman SM J Med Liban; 1974; 27(5):521-2. PubMed ID: 4443994 [No Abstract] [Full Text] [Related]
40. Gastroesophageal reflux disease: the roles of motility in pathophysiology and therapy. Quigley EM Am J Gastroenterol; 1993 Oct; 88(10):1649-51. PubMed ID: 8213704 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]